161 related articles for article (PubMed ID: 25181338)
1. The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth.
Zhang J; Liu H; Pan H; Yang Y; Huang G; Yang Y; Zhou WP; Pan ZY
Biochem Biophys Res Commun; 2014 Sep; 452(3):575-80. PubMed ID: 25181338
[TBL] [Abstract][Full Text] [Related]
2. hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2).
Li Q; Sun H; Shu Y; Zou X; Zhao Y; Ge C
Cell Prolif; 2015 Aug; 48(4):436-42. PubMed ID: 26032517
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-572/hMOF/Sirt6 regulates the progression of ovarian cancer.
Cai M; Hu Z; Han L; Guo R
Cell Cycle; 2020 Oct; 19(19):2509-2518. PubMed ID: 33026281
[TBL] [Abstract][Full Text] [Related]
4. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60.
Peng L; Ling H; Yuan Z; Fang B; Bloom G; Fukasawa K; Koomen J; Chen J; Lane WS; Seto E
Mol Cell Biol; 2012 Jul; 32(14):2823-36. PubMed ID: 22586264
[TBL] [Abstract][Full Text] [Related]
6. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma.
Poté N; Cros J; Laouirem S; Raffenne J; Negrão M; Albuquerque M; Bedossa P; Godinho Ferreira M; Ait Si Ali S; Fior R; Paradis V
Liver Int; 2020 Apr; 40(4):956-967. PubMed ID: 31943753
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma.
Wang Y; Zhang R; Wu D; Lu Z; Sun W; Cai Y; Wang C; Jin J
J Exp Clin Cancer Res; 2013 Feb; 32(1):8. PubMed ID: 23394073
[TBL] [Abstract][Full Text] [Related]
8. Acetylation of TIP60 at K104 is essential for metabolic stress-induced apoptosis in cells of hepatocellular cancer.
Fang X; Lu G; Ha K; Lin H; Du Y; Zuo Q; Fu Y; Zou C; Zhang P
Exp Cell Res; 2018 Jan; 362(2):279-286. PubMed ID: 29174981
[TBL] [Abstract][Full Text] [Related]
9. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
10. The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis.
Su J; Wang F; Cai Y; Jin J
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784169
[TBL] [Abstract][Full Text] [Related]
11. Modulations of hMOF autoacetylation by SIRT1 regulate hMOF recruitment and activities on the chromatin.
Lu L; Li L; Lv X; Wu XS; Liu DP; Liang CC
Cell Res; 2011 Aug; 21(8):1182-95. PubMed ID: 21502975
[TBL] [Abstract][Full Text] [Related]
12. The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.
Qiao W; Zhang W; Gai Y; Zhao L; Fan J
Biochem Biophys Res Commun; 2014 Jun; 448(4):379-84. PubMed ID: 24802406
[TBL] [Abstract][Full Text] [Related]
13. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
14. MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.
Wei S; Liu W; Sun N; Wu Y; Song H; Wang C; Wang S; Zou R; Lin L; Zeng K; Zhou B; Wang M; Luan R; Yang F; Zhao Y
Cancer Sci; 2021 May; 112(5):1865-1877. PubMed ID: 33544437
[TBL] [Abstract][Full Text] [Related]
15. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
16. Expression of hMOF, but not HDAC4, is responsible for the global histone H4K16 acetylation in gastric carcinoma.
Zhu L; Yang J; Zhao L; Yu X; Wang L; Wang F; Cai Y; Jin J
Int J Oncol; 2015; 46(6):2535-45. PubMed ID: 25873202
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
20. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
Mahati S; Xiao L; Yang Y; Mao R; Bao Y
Biochem Biophys Res Commun; 2017 May; 486(3):732-737. PubMed ID: 28342862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
